Article

Development and validation of blood-based prognostic biomarkers for severity of COVID disease outcome using EpiSwitch 3D genomic regulatory immuno-genetic profiling

2021-06-28

Abstract excerpt

The COVID-19 pandemic has raised several global public health challenges to which the international medical community have responded. Diagnostic testing and the development of vaccines against the SARS-CoV-2 virus have made remarkable progress to date. As the population is now faced with the complex lifestyle and medical decisions that come with living in a pandemic, a forward-looking understanding of how a COVID-...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 8196c0ed-6184-5bd8-90c4-ddb3e2e33920
DOI: 10.1101/2021.06.21.21259145

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Development and validation of blood-based prognostic biomarkers for severity of COVID disease outcome using EpiSwitch 3D genomic regulatory immuno-genetic profilingDOI 10.1101/2021.06.21.21259145Read

3D genomic capture of regulatory immuno-genetic profiles in COVID-19 patients for prognosis of severe COVID disease outcomeSemantic proximity Read

Identification of PBMC-based molecular signature associational with COVID-19 disease severitySemantic proximity Read

Blood transcriptomic analyses reveal persistent SARS-CoV-2 RNA and candidate biomarkers in post-COVID-19 conditionSemantic proximity Read

The Existence of At Least Three Genomic Signature Patterns and At Least Seven Subtypes of COVID-19 and the End of the DiseaseSemantic proximity Read

Differentiation of COVID-19 from other emergency infectious disease presentations using whole blood transcriptomics then rapid qPCR: a case-control and observational cohort studySemantic proximity Read

Genomic Biomarker Heterogeneities Between SARS-CoV-2 and COVID-19Semantic proximity Read

Systems-level profiling of early peripheral host-response landscape variations across COVID-19 severity states in an Indian cohort.Semantic proximity Read

A circulating proteome-informed prognostic model of COVID-19 disease activity that relies on routinely available clinical laboratoriesSemantic proximity Read

Minimalistic Transcriptomic Signatures Permit Accurate Early Prediction of COVID-19 MortalitySemantic proximity Read

Systems Biology and Bioinformatics approach to Identify blood based signatures molecules and drug targets of patient with COVID-19Semantic proximity Read

Transcriptomics secondary analysis of severe human infection with SARS-CoV-2 identifies gene expression changes and predicts three transcriptional biomarkers in leukocytesSemantic proximity Read

Combination of WFDC2, CHI3L1, and KRT19 in Plasma Defines a Clinically Useful Molecular Phenotype Associated with Prognosis in Critically Ill COVID-19 Patients.Semantic proximity Read